PTC Therapeutics :
PTCT
PTCT
Stock Data
$75.44
$1.34 (1.81%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
PTC Therapeutics Inc is a pioneering biopharmaceutical company dedicated to developing innovative medicines for people with rare disorders. With a global presence, it offers treatments for conditions like Duchenne muscular dystrophy, spinal muscular atrophy, and other rare diseases. Its product lineup includes Translarna, Emflaza, Upstaza, Tegsedi, Waylivra, and Evrysdi. The company is also advancing research in areas such as Huntington’s disease and amyotrophic lateral sclerosis through its development pipeline. Founded in 1998 and based in South Plainfield, New Jersey, PTC Therapeutics collaborates with leading healthcare organizations to enhance its reach and impact.
All PTC Therapeutics Articles
9 Articles